Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-000597

President and Head of R&D acquired 324,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nagendran Sukumar · President and Head of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 1 in the form +324,500 1,222,343 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +324,500 324,500 D
Loading xslF345X05/form4-01032025_100136.xml…